• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过环磷酸腺苷周转和3型环核苷酸磷酸二酯酶控制血小板活化。

Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.

作者信息

Feijge Marion A H, Ansink Karin, Vanschoonbeek Kristof, Heemskerk Johan W M

机构信息

Department of Biochemistry, University of Maastricht, P.O. Box 616, Maastricht, MD 6200, The Netherlands.

出版信息

Biochem Pharmacol. 2004 Apr 15;67(8):1559-67. doi: 10.1016/j.bcp.2003.12.028.

DOI:10.1016/j.bcp.2003.12.028
PMID:15041473
Abstract

Prostaglandin-induced cAMP elevation restrains key signaling pathways in platelet activation including Ca(2+) mobilization and integrin alphaIIbbeta3 affinity regulation. We investigated how cAMP turnover by cyclic nucleotide phosphodiesterases (PDEs) regulates platelet activation. In washed human platelets, inhibition of all PDEs and also specific inhibition of PDE3 but not of PDE5 suppressed thrombin-induced Ca(2+) responses. The effect of general PDE or PDE3 inhibition was accompanied by an increase in cAMP, and potentiated by Gs stimulation with prostaglandin E(1). In platelet-rich plasma, general or PDE3 inhibition blocked platelet aggregation, integrin activation, secretion and thrombin generation. In contrast, inhibition of PDE5 increased the cGMP level, but without significant influence on aggregation, alphaIIbbeta3 activation, secretion or procoagulant activity. Nitroprusside (nitric oxide) potentiated the effect of PDE5 inhibition in elevating cGMP. Nitroprusside inhibited platelet responses, but this was accompanied by elevation of cAMP. Together, these results indicate that cAMP is persistently formed in platelets, independently of agonist-induced Gs stimulation. PDE3 thus functions to keep cAMP at a low equilibrium level and reduce the cAMP-regulated threshold for platelet activation. This crucial role of PDE3, but not of PDE5, extends to all major processes in thrombus formation: assembly of platelets into aggregates, secretion of autocrine products, and procoagulant activity.

摘要

前列腺素诱导的环磷酸腺苷(cAMP)升高可抑制血小板活化中的关键信号通路,包括钙离子动员和整合素αIIbβ3亲和力调节。我们研究了环核苷酸磷酸二酯酶(PDEs)介导的cAMP周转如何调节血小板活化。在洗涤后的人血小板中,抑制所有PDEs以及特异性抑制PDE3而非PDE5可抑制凝血酶诱导的钙离子反应。一般PDE或PDE3抑制的作用伴随着cAMP的增加,并通过前列腺素E1刺激Gs而增强。在富含血小板的血浆中,一般或PDE3抑制可阻断血小板聚集、整合素活化、分泌和凝血酶生成。相反,抑制PDE5可增加环磷酸鸟苷(cGMP)水平,但对聚集、αIIbβ3活化、分泌或促凝活性无显著影响。硝普钠(一氧化氮)增强了PDE5抑制在升高cGMP方面的作用。硝普钠抑制血小板反应,但这伴随着cAMP的升高。总之,这些结果表明血小板中持续形成cAMP,与激动剂诱导的Gs刺激无关。因此,PDE3的作用是将cAMP维持在低平衡水平,并降低cAMP调节的血小板活化阈值。PDE3而非PDE5的这一关键作用延伸至血栓形成的所有主要过程:血小板聚集成聚集体、自分泌产物的分泌以及促凝活性。

相似文献

1
Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.通过环磷酸腺苷周转和3型环核苷酸磷酸二酯酶控制血小板活化。
Biochem Pharmacol. 2004 Apr 15;67(8):1559-67. doi: 10.1016/j.bcp.2003.12.028.
2
The effect of Sildenafil on human platelet secretory function is controlled by a complex interplay between phosphodiesterases 2, 3 and 5.西地那非对人血小板分泌功能的影响受磷酸二酯酶2、3和5之间复杂的相互作用控制。
Cell Signal. 2005 Mar;17(3):331-9. doi: 10.1016/j.cellsig.2004.07.007.
3
Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases.环磷酸鸟苷(cGMP)抑制型和刺激型环磷酸腺苷(cAMP)磷酸二酯酶对人血小板反应的差异调节。
Thromb Haemost. 2002 May;87(5):873-9.
4
Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.通过选择性抑制剂和cGMP升高剂抑制不同环核苷酸磷酸二酯酶同工型来调节大鼠胸腺细胞增殖反应。
Mol Pharmacol. 1993 Nov;44(5):1027-35.
5
Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.通过分隔的环核苷酸作用对人血小板中蛋白酶激活受体(PAR)1和PAR4信号传导的调节
J Pharmacol Exp Ther. 2007 Aug;322(2):778-88. doi: 10.1124/jpet.107.121830. Epub 2007 May 24.
6
Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis.血管内皮细胞环核苷酸磷酸二酯酶与调控的细胞迁移:对血管生成的影响
Mol Pharmacol. 2005 Jan;67(1):263-72. doi: 10.1124/mol.104.004853. Epub 2004 Oct 8.
7
Dipyridamole synergizes with nitric oxide to prolong inhibition of thrombin-induced platelet shape change.双嘧达莫与一氧化氮协同作用,延长抑制凝血酶诱导的血小板形态改变。
Platelets. 2011;22(1):8-19. doi: 10.3109/09537104.2010.517581. Epub 2010 Oct 19.
8
Nitric oxide-mediated regulation of connexin43 expression and gap junctional intercellular communication in mesangial cells.一氧化氮介导的系膜细胞中连接蛋白43表达及缝隙连接细胞间通讯的调控
J Am Soc Nephrol. 2005 Jan;16(1):58-67. doi: 10.1681/ASN.2004060453. Epub 2004 Nov 10.
9
Profiling of functional phosphodiesterase in mesangial cells using a CRE-SEAP-based reporting system.使用基于CRE-SEAP的报告系统对系膜细胞中的功能性磷酸二酯酶进行分析。
Br J Pharmacol. 2006 Jul;148(6):833-44. doi: 10.1038/sj.bjp.0706785. Epub 2006 Jun 5.
10
Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.黄酮类化合物对豚鼠磷酸二酯酶同工酶的抑制作用及其构效关系。
Biochem Pharmacol. 2004 Nov 15;68(10):2087-94. doi: 10.1016/j.bcp.2004.06.030.

引用本文的文献

1
Suppressed ORAI1-STIM1-dependent Ca entry by protein kinase C isoforms regulating platelet procoagulant activity.蛋白激酶C亚型通过调节血小板促凝血活性抑制ORAI1-STIM1依赖性钙内流。
J Biol Chem. 2024 Dec;300(12):107899. doi: 10.1016/j.jbc.2024.107899. Epub 2024 Oct 17.
2
Protein Kinase A Regulates Platelet Phosphodiesterase 3A through an A-Kinase Anchoring Protein Dependent Manner.蛋白激酶 A 通过依赖 A-激酶锚定蛋白的方式调节血小板磷酸二酯酶 3A。
Cells. 2024 Jun 26;13(13):1104. doi: 10.3390/cells13131104.
3
Venous Thrombosis in a Pseudohypoparathyroidism Patient with a Novel GNAS Frameshift Mutation and Complete Resolution of Vascular Calcifications with Acetazolamide Treatment.
假性甲状旁腺功能减退症患者伴新型 GNAS 框移突变致静脉血栓形成,乙酰唑胺治疗后血管钙化完全消退。
Horm Res Paediatr. 2024;97(4):404-415. doi: 10.1159/000534456. Epub 2023 Oct 31.
4
No impact of polymorphism in the phosphodiesterase 5A gene in Cavalier King Charles Spaniels on pimobendan-induced inhibition of platelet aggregation response.磷酸二酯酶 5A 基因多态性对可力犬比苯达唑诱导的血小板聚集反应抑制无影响。
J Vet Intern Med. 2023 Nov-Dec;37(6):2145-2156. doi: 10.1111/jvim.16871. Epub 2023 Sep 24.
5
Current concepts and novel targets for antiplatelet therapy.抗血小板治疗的当前概念和新靶点。
Nat Rev Cardiol. 2023 Sep;20(9):583-599. doi: 10.1038/s41569-023-00854-6. Epub 2023 Apr 4.
6
Ultra-high-throughput Ca assay in platelets to distinguish ITAM-linked and G-protein-coupled receptor activation.用于区分免疫受体酪氨酸激活基序(ITAM)相关和G蛋白偶联受体激活的血小板超高通量钙检测法。
iScience. 2021 Dec 31;25(1):103718. doi: 10.1016/j.isci.2021.103718. eCollection 2022 Jan 21.
7
Impaired iloprost-induced platelet inhibition and phosphoproteome changes in patients with confirmed pseudohypoparathyroidism type Ia, linked to genetic mutations in GNAS.确认患有ⅠA型假性甲状旁腺功能减退症的患者,其 iloprost 诱导的血小板抑制和磷酸化蛋白质组变化受损,与 GNAS 基因突变有关。
Sci Rep. 2020 Jul 9;10(1):11389. doi: 10.1038/s41598-020-68379-3.
8
Cilostazol for Secondary Prevention of Stroke: Should the Guidelines Perhaps Be Extended?西洛他唑用于卒中二级预防:指南是否应予以扩展?
Vasc Specialist Int. 2017 Sep;33(3):89-92. doi: 10.5758/vsi.2017.33.3.89. Epub 2017 Sep 30.
9
The Spatiotemporal Regulation of cAMP Signaling in Blood Platelets-Old Friends and New Players.血小板中cAMP信号的时空调节——老朋友与新参与者
Front Pharmacol. 2015 Nov 10;6:266. doi: 10.3389/fphar.2015.00266. eCollection 2015.
10
Effect of cilostazol on carotid intima-media thickness in type 2 diabetic patients without cardiovascular event.西洛他唑对无心血管事件的2型糖尿病患者颈动脉内膜中层厚度的影响。
Endocrine. 2014 Sep;47(1):138-45. doi: 10.1007/s12020-013-0120-y. Epub 2014 Jan 1.